Ñõ×÷ΪÈËÀàÒÔ¼°µØÇòÉϾø´ó´ó¶¼ÉúÎïÉúÑÄËù±ØÐèµÄÔªËØ£¬¼ÓÈë×ÅÎïÖÊ´úлÒÔ¼°ÄÜÁ¿µÄ±¬·¢¡£ÔÚÓÀÀû¼¯ÍÅÒ»Ñùƽ³£ÉúÑÄÖУ¬µÍÑõÊÇÒ»ÖÖ³£¼ûµÄÕ÷Ïó£¬ÀýÈ磬ÈËÌåÄÚ²¿µÄÕý³£ÐÄÀíÇéÐξÍÊÇÒ»ÖÖµÍÑõÇéÐΡ£ÀýÈ磬ÔÚÐÄ¡¢¸Î¡¢ÉöÄÚµÄÑõŨ¶ÈԼĪÔÚ4%-14%£»ÄÔÖеÄÑõŨ¶ÈԼĪÔÚ0.5%-7%Ö®¼ä[1]¡£ÎÒÃÇÔÚ˯¾õʱ´ú¿ÉÄ᷺ܻÆð¼äЪÐÔµÄȱÑõ£»ÉË¿ÚµÄÓúºÏÒ²ÊÇÒ»ÖÖȱÑõÇéÐΣ»±ðµÄ£¬Ëæן£°ÎµÄÉý¸ß£¬´óÆøѹµÄϽµ£¬¸ßº£°ÎµØÇøµÄÑõŨ¶ÈÏà¹ØÓÚº£Æ½Ãæ»á½µµÍ£¬´Ó¶øÐÎÕû×ÔÈ»µÄµÍÑõÇéÐΡ£
¹ØÓÚ¸ßÔµÍÑõµÄ²»Ë³Ó¦£¬»á±¬·¢ÖÖÖÖ¸÷ÑùµÄ¼±¡¢ÂýÐÔ¸ßÔ¼²²¡£¬ÑÏÖز»ÊÊÕßÉõÖÁ»á±¬·¢¸ßÔ·ÎË®Ö×ÒÔ¼°¸ßÔÄÔË®Öס£È»¶ø£¬ÎÒ¹úÓнü250Íòƽ·½¹«ÀïµÄÃæ»ýÊÇλÓÚ¸ßÔÖ®ÉÏ£¬ÉúÔÚÊÀÉÏÍòÍòÉú³Ý¡£±ðµÄ£¬Ã¿ÄêÓÐ×Å´ó×ÚµÄÓοÍÈ¥Íù¸ßÔÂÃÓΣ¬ÕâЩÓοÍÖУ¬ÓÐÐí¶àΪ¸ßÔ²»Ë³Ó¦Õß¡£Òò´Ë¹ØÓÚµÍÑõ˳Ӧ·Ö×Ó»úÖƵÄÑо¿½«ÓÐÖúÓÚ¶ÔÕâЩÈ˵ÄÌåÖʾÙÐÐÅжϣ¬²¢¾ÙÐÐÏìÓ¦µÄÖÎÁÆ¡£±ðµÄ£¬µÍÑõ´úлͨ·Óë¶àÖÖ¼²²¡ÈçÐÄѪ¹Ü¼²²¡£¬Ö×ÁöµÄ±¬·¢Éú³¤Ç×½üÏà¹Ø[2]¡£Ëæ×ÅÈ«ÇòÉú³ÝµÄ¿ìËÙÔöÌí£¬¸ßÔµÄÕ½ÂÔְλҲÓúÏÔÖ÷Òª¡£Òò´Ë£¬ÈËÃÇÔÚÒÑÍùµÄ20ÄêÀïͶÈëÁË´ó×ÚµÄÈËÁ¦ÎïÁ¦¾ÙÐеÍÑõ·Ö×Ó»úÖƵÄÑо¿¡£ÏÂÃæ¾ÍÏÖÔÚº£ÄÚÍâµÄÑо¿ÏÖ×´×öЩС½á¡£
×î³õ¹ØÓÚµÍÑõ·Ö×Ó»úÖÆÑо¿Ö÷Òª¼¯ÖÐÔÚÐÄÀí¼°±íÐÍˮƽ¡£ÈËÃÇ·¢Ã÷һЩÊÀ¾Ó¸ßÔµÄÈËÏà¹ØÓÚº£Æ½ÃæµÄÈ˶øÑÔ£¬¸ü˳ӦÔÚ¸ßÔÉúÑÄ¡£È磬°²µÚ˹ÈË£¬ÎÒ¹úµÄ²Ø×åÈ˵ȡ£Ñо¿Ö°Ô±Í¨¹ý½ÏÁ¿¸ßÔÈËȺÓëµÍº£°ÎÈËȺ֮¼äµÄһϵÁÐÐÄÀíÐÔ×´£¬ÀýÈ磬ѪºìÂÑ°×Ũ¶È£¬ÑªÑõ±¥ºÍ¶È£¬NOŨ¶È£¬ÑªÏ¸°û±ÈÈݵȣ¬À´ÆðÔ´Íƶϳö¿ÉÄÜÓëµÍÑõ˳ӦÏà¹ØµÄÐÔ×´£¬ÒÔ¼°Õâ¸öÐÔ×´¿ÉÄÜÉæ¼°µ½µÄͨ·¡£¿ÉÊÇ£¬²î±ðµÄÈËȺ¸ßÔ˳ӦµÄ»úÖÆÓÖËƺõÓвî±ð¡£ÀýÈ磬ÔÚÏàͬµÄº£°ÎÌõ¼þÏ£¬²Ø×åÈ˵ÄѪºìÂÑ°×ƽ¾ùŨ¶ÈÒª±È°²µÚ˹È˵Í3.6g/dl[3]¡£×î½üµÄÑо¿ÏÔʾ£¬°²µÚ˹ÈËȺͨ¹ý·Î¶¯Âö¸ßѹÀ´¼ÓËÙѪÁ÷ºÍÔö½ø·Î²¿ÑõÆø½»Á÷£¬¶ø²Ø×åÈËͨ¹ýÌáÉýѪҺÖÐNOº¬Á¿À´¼ÓËÙѪҺÁ÷ËÙÒÔ¼á³ÖÑõµÄ¹©Ó¦[4]¡£±ðµÄ£¬°£Èû¶í±ÈÑǸßÔÒ²ÆÜÉíןßÔÈËȺ£¬µ«ÓÉÓÚ´ËÈËȺÔÚ×é³ÉÉϽÏÁ¿Öش󣬿ÉÄÜÓµÓв»Ö¹Ò»ÖÖµÍÑõ˳Ӧ»úÖÆ¡£
Ëæ×ÅÈËÃǶÔÖÖÖÖ¼±ÂýÐÔ¸ßÔ¼²²¡µÄÊìϤµÄÉîÈ룬Ñо¿Ö°Ô±×îÏÈÓû¼ÖÖÖÖ¼±ÂýÐÔ¸ßÔ¼²²¡µÄÈËÓëÕý·²È˾ÙÐпÉÄܵĺòÑ¡»ùÒòµÄcase-controlÑо¿¡£Ï£Íûͨ¹ý¸ßÔ¼²²¡À´ÌáÐÑһЩ¿ÉÄÜÓëµÍÑõ˳ӦÏà¹ØµÄ»ùÒòÒÔ¼°Ïà¹ØµÄ·Ö×Óͨ·¡£²¢ÕÒµ½ÁËÐí¶à¿ÉÄÜÓëµÍÑõ˳ӦÏà¹ØµÄ»ùÒò£¬ÈçACE¡¢CYP11B2£¬NO´úлÏà¹ØµÄNOS1¡¢2¡¢3»ùÒò£¬ÒÔ¼°HIF1AºÍHIF2AµÈ[5]¡£È»¶ø£¬¹ØÓÚÕâЩ»ùÒòÔÚ²î±ðµÄÎÄÕÂÖеÄÖظ´ÐÔ²¢Ç·ºÃ£¬¿ÉÄÜÔÚһƪÎÄÏ×ÖÐ֤ʵ¿ÉÄÜÓëµÍÑõ˳ӦÏà¹Ø£¬¿ÉÊÇÔÚÁíÍâһƪÎÄÏ×ÖУ¬¿ÉÄܾÍÓëµÍÑõ˳ӦÎ޹ء£Òò´Ë£¬Ðí¶à»ùÒòÈÔÈ»ÓдýÓÚ½øÒ»²½µÄÑéÖ¤¡£²¢ÇÒ£¬ÈËÃǹØÓÚÕâЩ»ùÒòÖ®¼äÊÇÔõÑùÏ໥×÷ÓôӶø±¬·¢Ë³Ó¦µÄÐÄÀí״̬µÄÏêϸ»úÖƲ¢²»ÇåÎú¡£
Ëæ×ÅÈ«»ùÒò×é¹ØÁªÆÊÎö£¨GWAS£©ÒªÁìµÄÆÕ±éÔËÓã¬Ñо¿Ö°Ô±Ò²½«´ËÒªÁìÓÃÓÚÁ˵ÍÑõ˳ӦÏà¹ØºòÑ¡»ùÒòµÄɸѡ¡£2010¼¸¸ö×ÔÁ¦µÄÑо¿ÍŶӣ¬Ê¹ÓøßͨÁ¿·ÖÐÍÒÔ¼°Í³¼ÆѧÊֶΣ¬É¸Ñ¡³öÁËһϵÁпÉÄÜÓë²Ø×åÈ˵ÍÑõ˳ӦÏà¹ØµÄ»ùÒò£¬È磬EPAS1¡¢EGLN1¡¢PPARAµÈ£¬ÆäÖÐÒÔEPAS1ºÍEGLN1µÄÖظ´ÐÔ×îºÃ[6-9]¡£Cynthia M. BeallÍŽáѪºìÂÑ°×Ũ¶ÈµÄ±íÐÍÊý¾Ý£¬·¢Ã÷²Ø×åÈËȺÖÐÌØÓеÄEPAS1µ¥ÌåÐÍ¿ÉÄÜÓë²Ø×åÈËȺµÄµØѪºìÂÑ°×Ũ¶ÈÏà¹Ø¡£Óë´Ëͬʱ£¬BighamʹÓÃGWASÔÚ°²µÚ˹ÈËȺÖÐÕÒµ½Ò»Ð©»ùÒò¿ÉÄÜÓë°²µÚ˹È˵ĵÍÑõ˳ӦÏà¹Ø£¬µ«²¢Î´¼ì²âµ½EPAS1Ðźţ¬È´·¢Ã÷HBE1¡¢EGLN1¿ÉÄÜÔÚ°²µÚ˹ÈËȺµÄ¸ßÔµÍÑõ˳ӦÖÐÆð×÷ÓÃ[10]¡£Õ⼸ÏîÑо¿Í¨ÔÚÒ»¶¨Ë®Æ½ÉÏ֤ʵÁËÇ°Ãæ¹ØÓÚ²Ø×åÈËȺÓë°²µÚ˹ÈËȺµÄ¸ßÔµÍÑõ˳ӦµÄÐÄÀí»úÖƱ£´æ²î±ðÕâ¸ö¼ÙÉè¡£Õ⼸ÏîÑо¿ËäÈ»´ÓÈ«»ùÒò×éˮƽɸѡ³öÁËһϵÁпÉÄÜÓë¸ßÔµÍÑõ˳ӦÏà¹ØµÄ»ùÒò£¬µ«ÓÉÓÚËùÓõÄSNPs¶¼Îªcommon SNPs£¬ÒÔÊDz¢²»¿ÉÈ·¶¨ÄÄЩSNPs¶Ô»ùÒò±¬·¢Ó°Ï죬Òò´Ë»¹ÐèÒªÆäËûÒªÁìµÄÌî²¹¡£Í¬Ä꣬Xin Yi et al.¶Ô50¸ö²Ø×åÈ˾ÙÐÐÈ«ÍâÏÔ×Ó²âÐò£¬Ï£ÍûÄÜÕÒµ½Ò»Ð©ÓëµÍÑõ˳ӦÏà¹ØµÄ»ùÒòµÄÍ»±ä[11]¡£ËäÈ»ÔÚEPAS1µÈ»ùÒòÖÐÕÒµ½ÁËеÄÍ»±ä£¬µ«ÓÉÓÚÕâЩͻ±ä¾ø´ó´ó¶¼Î»ÓÚÄÚº¬×ÓÖУ¬Òò´Ë¶ÔÕâЩͻ±äµÄ¹¦Ð§²»¿É×ö³öºÜºÃµÄÔ¤¼Æ¡£
×ÛºÏÒÔÍùµÄÑо¿£¬HIF1AºÍHIF2A£¨EPAS1£©ÓëµÍÑõ˳ӦµÄÏà¹ØÐÔ×î´ó¡£¼ÓÉÏÖ×ÁöÑо¿ºÍģʽ¶¯ÎïµÍÑõµ÷Àí»úÖÆÑо¿£¬ÈËôÒѾ¶ÔµÍÑõ¸ÐÖª¼°µ÷ÀíµÄÐźÅͨ·ÓÐÁËÒ»¶¨µÄÏàʶ¡£¼´£¬ÔÚ³£Ñ¹³£ÑõÏ£¬HIF1AÒÔ¼°HIF2AÂѰ׻ᱻPHD2ÔÚpro402»òÕßpro564¾ÙÐÐôÇ»ù»¯£¬ôÇ»ù»¯ºóµÄHIF1A¡¢HIF2A»á±»VHL¾ÙÐзºËØ»¯£¬È»ºó¾ÓÉÂÑ°×øÌå½µ½â¡£ÔÚµÍÑõ״̬ÏÂHIF1AºÍHIF2A²»»á±»ôÇ»ù»¯£¬´Ó¶ø²»»á±»·ºËØ»¯ÔÙ±»ÂÑ°×øÌå½µ½â¡£Îȹ̱£´æµÄHIF1A¼°HIF2A¾Í»áÐÐʹÆäת¼Òò×ӵĹ¦Ð§£¬Ôö½ø±»Æäµ÷¿ØµÄ»ùÒòµÄ±í´ï¡£¿ÉÊÇHIF1AÒÔ¼°HIF2AµÄÏÂÓλùÒò¶¼ÓÐÄÄЩ£¬Æäʱ²¢²»ÊǺÜÊǵÄÇåÎú¡£
½üÁ½Ä꣬Ðí¶àÑо¿Ö°Ô±Ê¹ÓÃChIP-SeqµÄÊÖ¶ÎÒÔ¼°ÖÖÖÖÕý³£»òÖ×Áöϸ°ûϵ¾ÙÐÐHIF1AÒÔ¼°HIF2AµÄÏÂÓλùÒòÑо¿£¬»ñµÃÁ˼¸°Ù¸öºòÑ¡µÄHIF1AÒÔ¼°HIF2AµÄÏÂÓε÷¿Ø»ùÒò[12]¡£´ÓÕâЩºòÑ¡»ùÒòÁбíÖпÉÒÔ¿´³ö£¬HIF1AºÍHIF2AÓÐÒ»²¿·Öµ÷ÀíµÄ»ùÒòÊÇÏàͬµÄ£¬µ«Ò²Óи÷×ÔÌØÓеÄһЩµ÷Àí»ùÒò¡£¿ÉÊÇ˼Á¿µ½»ùÒò±í´ïµÄ×éÖ¯ÌØÒìÐÔ£¬Ê¹ÓÃϸ°ûϵÀ´×öChIP-SeqÑо¿£¬ÆäЧ¹û»áÓÐÒ»¶¨µÄ¾ÖÏÞÐÔ£¬¼´¿ÉÄÜ»áɥʧһ²¿·ÖÐÅÏ¢¡£±ðµÄ£¬ÔÚÖ×ÁöµÄ±¬·¢Éú³¤ÖУ¬ÒÔÍùÈËÃÇÒÔΪHIF1AºÍHIF2Aͨ¹ýÏ໥Ðͬ´Ó¶øÔö½øÖ×ÁöµÄ±¬·¢ºÍÉú³¤£¬¿ÉÊÇ×î½üÔ½À´Ô½¶àµÄÊÂʵ֤ʵ£¬Í¨¹ýHIF1AºÍHIF2A¸÷×ÔÌØÓеÄÏÂÓαí´ï»ùÒò£¬HIF1AºÍHIF2AÓÐʱ»áÌåÏÖ³öÏà·´µÄ¹¦Ð§[13]¡£
×ÛÉÏËùÊö£¬ÓÉÓÚÒªÁìºÍʵÑéÑù±¾µÄÏÞÖÆ£¬ÎÒÃǹØÓÚµÍÑõµÄ·Ö×Ó»úÖÆÏàʶµÄÕվɺÜÉÙ¡£ÒÔºóµÄÑо¿Ó¦¸Ã´Ó²î±ðµÄ²ãÃæϵͳµÄ¾ÙÐС£È磬´ÓÈ«»ùÒò×顢ת¼×éÒÔ¼°±í¹ÛÒÅ´«×éµÈ¶à·½Ãæ·½Ã棬¶ÔÏàͬµÄÑù±¾¾ÙÐÐÉî¶ÈÍÚ¾ò£»×ۺϲî±ðµ÷¿ØˮƽµÄЧ¹ûÐγÉϵͳµÄÊìϤ¡£
²Î¿¼ÎÄÏ×£º
1.¡¡ Ivanovic, Z., Hypoxia or in situ normoxia: The stem cell paradigm. J Cell Physiol, 2009. 219(2): p. 271-5.
2.¡¡ Lendahl, U., et al., Generating specificity and diversity in the transcriptional response to hypoxia. Nat Rev Genet, 2009. 10(12): p. 821-32.
3.¡¡ Beall, C.M., et al., Hemoglobin Concentration of High-Altitude Tibetans and Bolivian Aymara. American Journal of Physical Anthropology, 1998. 106: p. 385-400.
4.¡¡ Beall, C.M., Two routes to functional adaptation: Tibetan and Andean high-altitude natives. Proc Natl Acad Sci U S A, 2007. 104 Suppl 1: p. 8655-60.
5.¡¡ MacInnis, M.J., M.S. Koehle, and J.L. Rupert, Evidence for a genetic basis for altitude illness: 2010 update. High Alt Med Biol, 2010. 11(4): p. 349-68.
6.¡¡ Beall, C.M., et al., Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders. Proc Natl Acad Sci U S A, 2010. 107(25): p. 11459-64.
7.¡¡ Simonson, T.S., et al., Genetic evidence for high-altitude adaptation in Tibet. Science, 2010. 329(5987): p. 72-5.
8.¡¡ Xu, S., et al., A genome-wide search for signals of high-altitude adaptation in Tibetans. Mol Biol Evol, 2011. 28(2): p. 1003-11.
9.¡¡ Peng, Y., et al., Genetic variations in Tibetan populations and high-altitude adaptation at the Himalayas. Mol Biol Evol, 2011. 28(2): p. 1075-81.
10. Bigham, A., et al., Identifying Signatures of Natural Selection in Tibetan and Andean Populations Using Dense Genome Scan Data. PLoS Genet, 2010. 6(9).
11. Yi, X., et al., Sequencing of 50 human exomes reveals adaptation to high altitude. Science, 2010. 329(5987): p. 75-8.
12. Schodel, J., et al., High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood, 2011. 117(23): p. e207-17.
13. Keith, B., R.S. Johnson, and M.C. Simon, HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer, 2011. 12(1): p. 9-22.